These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22037060)

  • 1. Neutrophil dynamics in response to chemotherapy and G-CSF.
    Zhuge C; Lei J; Mackey MC
    J Theor Biol; 2012 Jan; 293():111-20. PubMed ID: 22037060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil dynamics after chemotherapy and G-CSF: the role of pharmacokinetics in shaping the response.
    Brooks G; Provencher G; Lei J; Mackey MC
    J Theor Biol; 2012 Dec; 315():97-109. PubMed ID: 22981924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical model for G-CSF administration after chemotherapy.
    Foley C; Mackey MC
    J Theor Biol; 2009 Mar; 257(1):27-44. PubMed ID: 19007795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia.
    Ricotta R; Cerea G; Schiavetto I; Maugeri MR; Pedrazzoli P; Siena S
    Future Oncol; 2006 Dec; 2(6):667-76. PubMed ID: 17155894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncaria tomentosa stimulates the proliferation of myeloid progenitor cells.
    Farias I; do Carmo Araújo M; Zimmermann ES; Dalmora SL; Benedetti AL; Alvarez-Silva M; Asbahr AC; Bertol G; Farias J; Schetinger MR
    J Ethnopharmacol; 2011 Sep; 137(1):856-63. PubMed ID: 21771655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
    Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation.
    Shimazaki C; Oku N; Uchiyama H; Yamagata N; Tatsumi T; Hirata T; Ashihara E; Okawa K; Goto H; Inaba T
    Bone Marrow Transplant; 1994 Mar; 13(3):271-5. PubMed ID: 7515300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of hematopoiesis: II. Cyclical neutropenia.
    Colijn C; Mackey MC
    J Theor Biol; 2005 Nov; 237(2):133-46. PubMed ID: 15975606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
    N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling of granulocyte reconstitution after high-dose chemotherapy with stem cell support: effect of post-transplant G-CSF treatment.
    Østby I; Kvalheim G; Rusten LS; Grøttum P
    J Theor Biol; 2004 Nov; 231(1):69-83. PubMed ID: 15363930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF control of neutrophils dynamics in the blood.
    Shochat E; Rom-Kedar V; Segel LA
    Bull Math Biol; 2007 Oct; 69(7):2299-338. PubMed ID: 17554586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E; Rom-Kedar V
    Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma.
    Czygier M; Dakowicz Ł; Szmitkowski M
    Adv Med Sci; 2007; 52():143-6. PubMed ID: 18217407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.